Infection is one of the most common causes of diseases, and several of these infections have proved a pestilence. In the current scenario, the COVID-19 epidemic is the world’s deadliest infection, killing over 340,000 people as of May 2020, since being detected in December 2019. Due to the rapidly increasing number cases and deaths, the adopted of microbial identification methods is increasing around the world, to ascertain whether someone has the virus or not, and if not, which other microbe could be causing the symptoms.

Apart from coronavirus, several other microbial infections have ran riot on the earth, including human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (HIV/AIDS), measles, polio, Zika, cholera, tuberculosis, anthrax, leprosy, dengue fever, malaria, and bubonic plague. Due to the rising prevalence of many such pathogen-borne diseases, the microbial identification market is growing rapidly across the world. Several consumables, services, and instruments and software are required to efficiently establish the presence of microorganisms in a given sample. Among them, consumables are the most widely bought around the world, as reagents, kits, media, and plates are used in every individual test, so they deplete rather quickly.

Browse detailed - Microbial Identification Market Revenue Estimation and Growth Forecast Report

In the coming years, Asia-Pacific (APAC) would observe microbial identification market growth at the highest rate, on account of the rising incidence of infectious diseases here, primarily due to the booming population of the elderly. Due to their weakened immunological response, the geriatric population is more prone to infections, which also affect them more severely than other people. Similarly, the biotechnology and pharmaceutical sectors are also expanding in the region, which are also significant users of the various services, software, instruments, and consumables that make microbial identification possible.

Therefore, due to the rising menace of infections, presently COVID-19, as well as the expansion of the biotech, pharma, and food and beverage sectors, the adoption of microbial identification methods will keep rising.